The Scandinavian Solutions for Wellness study - a two-arm observational study on the effectiveness of lifestyle intervention on subjective well-being and weight among persons with psychiatric disorders
Open Access
- 10 June 2010
- journal article
- research article
- Published by Springer Nature in BMC Psychiatry
- Vol. 10 (1) , 42
Abstract
Solutions for Wellness (SfW) is an educational 3-month program concerning nutrition and exercise for persons with psychiatric disorders on psychotropic medication, who have weight problems. This observational study assessed the impact of SfW on subjective well-being, weight and waist circumference (WC). Data was collected at 49 psychiatric clinics. Where the SfW program was offered patients could enter the intervention group; where not, the control group. Subjective well-being was measured by the Subjective Well-being under Neuroleptics scale (SWN), at baseline, at the end of SfW participation, and at a follow-up 6 months after baseline. Demographic, disease and treatment data was also collected. 314 patients enrolled in the SfW group, 59 in the control group. 54% of the patients had schizophrenia, 67% received atypical antipsychotics, 56% were female. They averaged 41 ± 12.06 years and had a BMI of 31.4 ± 6.35. There were significant differences at baseline between groups for weight, SWN total score and other factors. Stepwise logistic models controlling for baseline covariates yielded an adjusted non-significant association between SfW program participation and response in subjective well-being (SWN increase). However, statistically significant associations were found between program participation and weight-response (weight loss or gain < 1 kg) OR = 2; 95% CI [1.1; 3.7] and between program participation and WC-response (WC decrease or increase < 2 cm) OR = 5; 95% CI [2.4; 10.3]), at 3 months after baseline. SfW program participation was associated with maintaining or decreasing weight and WC but not with improved subjective well-being as measured with the SWN scale.Keywords
This publication has 39 references indexed in Scilit:
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and AdolescentsJAMA, 2009
- Efficacy of behavioural interventions in managing atypical antipsychotic weight gainObesity Reviews, 2009
- Weight management in a cohort of Irish inpatients with serious mental illness (SMI) using a modular behavioural programme. A preliminary service evaluationBMC Psychiatry, 2008
- A Naturalistic Multicenter Trial of a 12-Week Weight Management Program for Overweight and Obese Patients With Schizophrenia or Schizoaffective DisorderThe Journal of Clinical Psychiatry, 2008
- A Psychoeducational Program for Weight Loss in Patients who have Experienced Weight Gain during Antipsychotic Treatment with OlanzapinePharmacopsychiatry, 2008
- Cognitive behavioural therapy for weight gain associated with antipsychotic drugsSchizophrenia Research, 2007
- Primary Prevention of Ischemic StrokeStroke, 2006
- Weight Management Program for Treatment-Emergent Weight Gain in Olanzapine-Treated Patients With Schizophrenia or Schizoaffective DisorderThe Journal of Clinical Psychiatry, 2006
- Nutritional Intervention to Prevent Weight Gain in Patients Commenced on Olanzapine: A Randomizedcontrolled TrialAustralian & New Zealand Journal of Psychiatry, 2005
- Bodyweight Change as an Adverse Effect of Drug TreatmentDrug Safety, 1996